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Informed consent in clinical practice is a process in which a
patient consents to participate or undergo the proposed proce-
dures after being informed of its procedures, risks, and benefits.
Ideally, the patient is expected to give his/her consent solely after
fully understanding the information about the procedures, bene-
fits, and risks involved in the practice. According to the doctrine,
the necessary information should be given by the physician and
he/she should also respect the decision of the patient which is
based on this information.1 Although the importance of providing-
information about the proposed treatment’s effects and side effects
to children and adolescents before treatment is accepted by physi-
cians, this issue is given little importance in research and case pre-
sentations.2 In this case, it was aimed to discuss the importance of
informed consent and multi-disciplinary approach in treatment by
presenting an adolescent patient who was diagnosed with palatal
myoclonus and treated with botulinum toxin. Although the neuro-
logical treatment was effective, the patient developed adjustment
disorder (with depressive mood) due to dysphonia after the
procedure.
2. Case report
A 14-year-old female high school junior, applied to our outpa-
tient department with a complaint of ‘‘clicking sounds” in her ears.
It was learned from the history that those sounds began one year
ago, involved a tinnitus barely noticeable by the patient at first,gradually became more intense and culminating in being audible
by her peers and family 4–5 months ago. The sounds even pre-
vented her falling asleep. There were no other complaints. Baseline
mental status examination was normal and there was no family
history of psychopathology. A preliminary diagnosis of palatal
myoclonus was made and she was directed to the otolaryngology
and neurology outpatient clinic where the final diagnosis of
essential palatal myoclonus was corroborated. The patient and
her parents were informed about the diagnosis but as learned later,
were not informed about treatment options, effects and side
effects. After a two-week trial of carbamazepine 200 mg/day
without benefit, the patient was injected with botulinum toxin.
The botulinum toxin injection helped control palatal myoclonus
and clicking sounds. However, she applied again to our department
a week after the injection with complaints of ‘‘continuous crying,
not going to school, lack of sleep, social isolation”. It was learned
from the history that those complaints started after the injection
and that she was unaware of potential side effects of botulinum
toxin injection, especially dysphonia. She reported social avoidance
due to dysphonia and blamed herself for accepting the treatment.
She was hopeless about remission of this side effect and prepared
to stay at home for its duration. Evaluation with CGI-S and BDI
revealed scores of 4 (moderately impaired) and 12 (mild depres-
sive symptoms); respectively. Mental status examination revealed
depressed mood and affect, anhedonia, reduced appetite and sleep.
History, mental status examination and psychometric tests sup-
ported the diagnosis of adjustment disorder (with depressive
mood) according to DSM-IV-TR criteria. Neurology and otolaryn-
gology departments were contacted and detailed information
about palatal myoclonus, its treatments and side effects was given.
She was reassured that the dysphonia after injectionwill remit
within one to two months and sertraline started 50 mg/day. The
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symptoms remitted dramatically at the second week while dys-
phonia was still continuing. In the meantime she started attending
school after a week of rest at home. At the fourth week dysphonia
started to reduce and ceased at the 6th week. Sertraline was con-
tinued until the 12th week and was gradually tapered thereafter.
At the 16th week the patient was free of symptoms. CGI-S and
BDI scores were 1 (Normal) and 1 (no depressive symptoms).
3. Discussion
Here we report an adolescent patient who developed
adjustment disorder due to adverse effects of botulinum injection
to control her palatal myoclonus. Agents including barbiturates,
phenytoin, carbamazepine, clonazepam and anticonvulsants/anxi-
olytics, and sedatives are used in management of palatal myoclo-
nus. Botulinum toxin (BT) treatment is also used. BT acts by
preventing release of acetylcholine into the neuromuscular junc-
tion and autonomic synapses.3 There have been a few small case
series documenting the success and side effects of botulinum toxin
injections for treatment of palatal myoclonus. Reported side effects
include dysphonia, hypernasality, velopharyngeal insufficiency
(VPI) leading to nasopharyngeal regurgitation, dysphagia, and need
for repeat injections.4 ‘‘Dysphonia” side effect, which our patient
perceived as ‘‘unexpected and ‘‘traumatic”, was experienced by
her for the first time in school beside her friends and led to avoid-
ance and psychiatric symptoms and complaints because she was
not been adequately informed about pre-treatment effects and
adverse effects. So she met adjustment disorder (with depressive
mood) criteria for DSM-IV-TR. The exact cause of adjustment disor-ders have not been determined to date, but likely are a result of the
interaction of genetics, exposure to stressors, and altered levels of
certain chemicals in the brain. One or more stressful life events, a
continuous or recurrent stressor, or a stressor associated with a life
stage increases the risk that an adjustment disorder will develop.5
In the treatment of childhood and adolescent neuropsychiatric
disorders, providing information about the treatment options,
effects and side effects to the family and the child can improve
their participation in the process and can also improve the
patient-physician relationship and can increase the compliance.
In children and adolescents who are followed up due to medical
problems, consultation with child and adolescent psychiatrists
may reduce the problems that may be experienced.
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